Int. J. Mol. Sci. 2012, 13(5), 6352-6369; doi:10.3390/ijms13056352
Article

Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D

1 Department of Life Science, Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106, Taiwan 2 Institute of Biomedical Informatics, Center for Systems and Synthetic Biology, National Yang-Ming University, Taipei 112, Taiwan 3 Institute of Information Science, Research Center for Information Technology Innovation, Academia Sinica, Taipei 115, Taiwan 4 Biodiversity Research Center and Genomics Research Center, Academia Sinica, Taipei 115, Taiwan 5 Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637, USA
* Authors to whom correspondence should be addressed.
Received: 9 April 2012; in revised form: 9 May 2012 / Accepted: 18 May 2012 / Published: 23 May 2012
(This article belongs to the Special Issue Advances in Molecular Oncology)
PDF Full-text Download PDF Full-Text [785 KB, uploaded 23 May 2012 09:35 CEST]
Abstract: microRNAs (miRNAs) cause mRNA degradation or translation suppression of their target genes. Previous studies have found direct involvement of miRNAs in cancer initiation and progression. Artificial miRNAs, designed to target single or multiple genes of interest, provide a new therapeutic strategy for cancer. This study investigates the anti-tumor effect of a novel artificial miRNA, miR P-27-5p, on breast cancer. In this study, we reveal that miR P-27-5p downregulates the differential gene expressions associated with the protein modification process and regulation of cell cycle in T-47D cells. Introduction of this novel artificial miRNA, miR P-27-5p, into breast cell lines inhibits cell proliferation and induces the first “gap” phase (G1) cell cycle arrest in cancer cell lines but does not affect normal breast cells. We further show that miR P-27-5p targets the 3′-untranslated mRNA region (3′-UTR) of cyclin-dependent kinase 4 (CDK4) and reduces both the mRNA and protein level of CDK4, which in turn, interferes with phosphorylation of the retinoblastoma protein (RB1). Overall, our data suggest that the effects of miR p-27-5p on cell proliferation and G1 cell cycle arrest are through the downregulation of CDK4 and the suppression of RB1 phosphorylation. This study opens avenues for future therapies targeting breast cancer.
Keywords: miR P-27-5p; exon array; cyclin-dependent kinase 4; cell cycle; breast cancer; retinoblastoma protein

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Tseng, C.-W.; Huang, H.-C.; Shih, A.-C.; Chang, Y.-Y.; Hsu, C.-C.; Chang, J.-Y.; Li, W.-H.; Juan, H.-F. Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D. Int. J. Mol. Sci. 2012, 13, 6352-6369.

AMA Style

Tseng C-W, Huang H-C, Shih A-C, Chang Y-Y, Hsu C-C, Chang J-Y, Li W-H, Juan H-F. Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D. International Journal of Molecular Sciences. 2012; 13(5):6352-6369.

Chicago/Turabian Style

Tseng, Chien-Wei; Huang, Hsuan-Cheng; Shih, Arthur Chun-Chieh; Chang, Ya-Ya; Hsu, Chung-Cheng; Chang, Jen-Yun; Li, Wen-Hsiung; Juan, Hsueh-Fen. 2012. "Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D." Int. J. Mol. Sci. 13, no. 5: 6352-6369.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert